We are live on ! Find out more
DWA

Dorsey Wright & Associates Portfolio holdings

AUM $590M
1-Year Est. Return 77.57%
This Fund
S&P 500
This Quarter Est. Return
+2.45%
1 Year Est. Return
+77.57%
3 Year Est. Return
+310.64%
5 Year Est. Return
10 Year Est. Return
AUM
$456M
AUM Growth
-$12.9M
Cap. Flow
-$5.9M
Cap. Flow %
-1.29%
Top 10 Hldgs %
19.74%
Holding
376
New
89
Increased
141
Reduced
53
Closed
93

Top Sells

Rank Stock Value
1
FCX icon
Freeport-McMoran
FCX
+$7.52M
2
SBSW icon
Sibanye-Stillwater
SBSW
+$7M
3
SAM icon
Boston Beer
SAM
+$6.82M
4
BNTX icon
BioNTech
BNTX
+$5.98M
5
NWSA icon
News Corp Class A
NWSA
+$5.22M

Sector Composition

Rank Sector Weight
1 Technology 14.93%
2 Materials 13.41%
3 Healthcare 13.08%
4 Industrials 11.79%
5 Financials 11.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APEN
151
DELISTED
Apollo Endosurgery, Inc.
APEN
$75K 0.02%
8,325
+652
+8% +$5.61K
INVE icon
152
Identive
INVE
$64.1M
$74K 0.02%
3,918
+308
+9% +$5.24K
TGH
153
DELISTED
Textainer Group Holdings limited
TGH
$70K 0.02%
1,996
+156
+8% +$5.1K
STGW icon
154
Stagwell
STGW
$2.28B
$69K 0.02%
9,054
+712
+9% +$4.75K
BNED icon
155
Barnes & Noble Education
BNED
$424M
$68K 0.01%
68
+6
+10% +$5.29K
PAVM icon
156
PAVmed
PAVM
$33.9M
$68K 0.01%
18
+2
+13% +$6.31K
UAN icon
157
CVR Partners
UAN
$1.26B
$68K 0.01%
979
+76
+8% +$4.58K
MYRG icon
158
MYR Group
MYRG
$5.1B
$67K 0.01%
678
+52
+8% +$5.12K
PACK icon
159
Ranpak Holdings
PACK
$479M
$67K 0.01%
2,512
+196
+8% +$5.51K
PDSB icon
160
PDS Biotechnology
PDSB
$13M
$66K 0.01%
4,425
+348
+9% +$4.34K
CNR
161
Core Natural Resources Inc
CNR
$4.64B
$64K 0.01%
+2,442
New +$53.7K
MCB icon
162
Metropolitan Bank Holding Corp
MCB
$1.17B
$63K 0.01%
753
+60
+9% +$4.37K
ASIX icon
163
AdvanSix
ASIX
$446M
$62K 0.01%
1,566
+124
+9% +$4.26K
CCRN
164
DELISTED
Cross Country Healthcare
CCRN
$62K 0.01%
2,940
+232
+9% +$4.35K
CLMT icon
165
Calumet Specialty Products
CLMT
$4.29B
$62K 0.01%
7,790
+612
+9% +$4.21K
III icon
166
Information Services Group
III
$250M
$60K 0.01%
8,416
+660
+9% +$4.39K
KRUS icon
167
Kura Sushi USA
KRUS
$646M
$60K 0.01%
1,365
+108
+9% +$5K
TRNS icon
168
Transcat
TRNS
$888M
$60K 0.01%
935
+72
+8% +$4.59K
GNK icon
169
Genco Shipping & Trading
GNK
$1.13B
$59K 0.01%
2,947
+232
+9% +$4.29K
KNTK icon
170
Kinetik
KNTK
$4.16B
$59K 0.01%
1,702
+136
+9% +$4.47K
SB icon
171
Safe Bulkers
SB
$781M
$59K 0.01%
+11,377
New +$43.9K
ATTO
172
DELISTED
Atento S.A.
ATTO
$59K 0.01%
2,080
+164
+9% +$4.21K
STKS icon
173
The ONE Group
STKS
$56.8M
$58K 0.01%
5,429
+429
+9% +$4.42K
DSX icon
174
Diana Shipping
DSX
$307M
$57K 0.01%
14,139
+1,110
+9% +$3.67K
MVBF icon
175
MVB Financial
MVBF
$397M
$57K 0.01%
1,329
+104
+8% +$4.24K

Similar funds

Dorsey Wright & Associates's Q3 2021 Portfolio in Review

As of Q3 2021, Dorsey Wright & Associates held 376 positions worth $456M, down 2.7% from $469M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Dorsey Wright & Associates's Q3 2021 filing shows 89 new, 141 increased, 53 reduced and 93 closed positions. Its largest new stake was NovaBridge Biosciences American Depositary Shares: 69,882 shares worth $5.07M. The largest sale was Freeport-McMoran, an estimated $7.52M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Materials and Healthcare.

  • Dorsey Wright & Associates's largest Q3 2021 buy was NovaBridge Biosciences American Depositary Shares: 69,882 shares worth $5.07M.
  • Dorsey Wright & Associates added most to Devon Energy in Q3 2021, an estimated $5.49M increase.
  • Dorsey Wright & Associates's biggest Q3 2021 reduction was BioNTech, cutting an estimated $5.98M.
  • Dorsey Wright & Associates fully exited Freeport-McMoran in Q3 2021, selling an estimated $7.52M.
  • Dorsey Wright & Associates's ten largest holdings make up 20% of its $456M portfolio in Q3 2021.
  • Dorsey Wright & Associates opened 89 new positions and closed 93 in Q3 2021.
  • Dorsey Wright & Associates's portfolio value fell 2.7% quarter-over-quarter to $456M.

Based on Dorsey Wright & Associates's 13F filing for Q3 2021, filed 26 Oct 2021.